Biotech Values

[DewDiligence]

There's always Genta, pushing $1B in deficit, trading for a penny with 2B+ shares outstanding, negative net cash and oblivious shareholders.

Not to mention the most active “biotech” board on iHub:

http://investorshub.advfn.com/boards/most_read.aspx

As the saying goes, hydrogen and stupidity :- )